Announcements Trials
Browse Landscape

Status

Approved for marketing 2

Sponsor Class

OTHER 2

Study Type

Interventional 1059Observational 20Expanded_access 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Wounds and Injuries 1Pancreatic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

3-Iodobenzylguanidine 6Magnetic Resonance Spectroscopy 5Amifampridine 5gallium 68 PSMA-11 4fludarabine phosphate 3Cyclophosphamide 3pembrolizumab 2fluorodopa F 18 2fludarabine 2carbon-11 acetate 2Whole-Body Irradiation 2Oxaliplatin 2Ga(III)-DOTATOC 2Fluorouracil 2Bortezomib 2Bone Marrow Transplantation 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2venetoclax 1veliparib 1ulocuplumab 1trametinib 1selinexor 1ponatinib 1pegfilgrastim 1omburtamab I-131 1nirogacestat 1neratinib 1navitoclax 1motexafin gadolinium 1mifamurtide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Expanded_access × Fluorouracil × Clear all
NCT02436044 2019-08-20

HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC

Sun Yat-sen University

Approved for marketing
Gastrointestinal

Carcinoma, Hepatocellular, Wounds and Injuries

NCT00786058 2009-06-15

A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003

CONKO-Studiengruppe

Approved for marketing
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡